Seminars in Radiation Oncology
Volume 18, Issue 3 , Pages 186-193, July 2008

The Role of Physicians and Medical Organizations in the Development, Analysis, and Implementation of Health Care Policy

  • David C. Beyer, MD, FACR, FACRO, FASTRO

      Affiliations

    • Corresponding Author InformationAddress reprint requests to David Beyer, MD, FACR, FACRO, FASTRO, Arizona Oncology Services, 8994 E Desert Cove, Suite 100, Scottsdale, AZ 85260.
  • ,
  • Najeeb Mohideen, MD

Arizona Oncology Services, Scottsdale, AZ; and Department of Radiation Oncology, Northwest Community Hospital, Arlington Heights, IL.

Health policy is developed in the United States through a complicated interplay of governmental and private agencies and businesses, physician organizations, and societies as well as a host of other private ventures. The end result is rarely precisely what any individual or group may desire as the consequences of any action are never entirely predictable. There are many pathways to influence policy development within this system, and many of these are influenced by physicians as individuals and through organized medical societies. Opportunities abound to constructively engage the system, and it is important that physicians operating within this system understand where and how they may influence policy development. Changes are made or considered on a daily basis that impact patient's access to care, implementation and access to technological and biological innovation, reporting requirements, insurance, physician's reimbursement, and so on. This article reviews the most important channels by which physician input is incorporated in the system. The role of specialty societies, general medical societies, Congress, and Centers for Medicare and Medicaid Services are reviewed. The role of other players will also be addressed to show the many routes by which policy may evolve. Much of the discussion revolves around reimbursement because reimbursement often determines the availability and use of procedures and technology for our patients.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-4296(08)00018-0

doi:10.1016/j.semradonc.2008.01.006

Seminars in Radiation Oncology
Volume 18, Issue 3 , Pages 186-193, July 2008